1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Sleep-Disordered Breathing: new trials by email Literature Review of Sleep-Disordered Breathing trials Research Report on Sleep-Disordered Breathing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders NT 201, a Botulinum neurotoxin type A, free of complexing proteins - Sleep-Disordered Breathing | Phase 2 | Withdrawn | Merz Pharmaceuticals GmbH | 2010-03-01 | 2015-03-30 |
Sleep Apnea Syndromes (1) · Snoring (1)
Apnea (1) · Dyssomnias (1) · Nervous System Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Sounds (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Botulinum Toxins, Type A (1) · incobotulinumtoxinA (1)